Vitalunga

Vitalunga is a pioneering biotechnology research company dedicated to developing innovative solutions for healthy aging. Specializing in the discovery and development of novel small-molecule drugs, Vitalunga focuses on enhancing autophagy and mitophagy to combat aging-associated diseases. The company's cutting-edge research aims to address conditions such as Alzheimer’s and Parkinson’s diseases, congestive heart failure, sarcopenia, and age-related macular degeneration (AMD) through a single oral agent.

Based in Jerusalem, Vitalunga is committed to advancing the science of cellular rejuvenation. The company’s proprietary platform is designed to ensure the perpetual rejuvenation of cells in diseased tissues, offering a unified target for the prevention and treatment of multiple aging-related diseases. Vitalunga's work is driven by a passion for innovation and a dedication to improving the quality of life for individuals worldwide. The company is located in Jerusalem, IL.

Vitalunga continues to push the boundaries of biotechnology research, striving to create impactful therapies that promote disease-free aging. We invite the management team at Vitalunga to create a customized and exclusive company showcase and product listing on our platform, to further highlight their innovative work.